Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties.
Larsen CP, Pearson TC, Adams AB, Tso P, Shirasugi N, Strobert E, Anderson D, Cowan S, Price K, Naemura J, Emswiler J, Greene J, Turk LA, Bajorath J, Townsend R, Hagerty D, Linsley PS, Peach RJ.
Larsen CP, et al. Among authors: cowan s.
Am J Transplant. 2005 Mar;5(3):443-53. doi: 10.1111/j.1600-6143.2005.00749.x.
Am J Transplant. 2005.
PMID: 15707398
Free article.